MDMA-Assisted Therapy for Mental Healthcare Providers

Summary

This is a phase 1, open-label study to assess changes in mental well-being following MDMA administration within a therapeutic setting, in mental health providers who are in training to become MDMA assisted therapists. Secondary outcome measures will examine the effects on provider burnout, provider self-efficacy, mood, self-compassion, quality of life, and other psychological factors. Participants will work with a co-therapy pair as they engage in a preparatory session, one experimental session with MDMA, and an integration session the following day.

Timeline

Start

2026-02-11

Primary completion

2029-09-21

Completion

2029-12-21

Drugs

Indications

No indication recorded.